|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kneuertz PJ, Cunningham SC, Cameron JL,
Torrez S, Tapazoglou N, Herman JM, Makary MA, Eckhauser F, Wang J,
Hirose K, et al: Palliative surgical management of patients with
unresectable pancreatic adenocarcinoma: Trends and lessons learned
from a large, single institution experience. J Gastrointest Surg.
15:1917–1927. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wright GP, Poruk KE, Zenati MS, Steve J,
Bahary N, Hogg ME, Zuriekat AH, Wolfgang CL, Zeh HJ III and Weiss
MJ: Primary tumor resection following favorable response to
systemic chemotherapy in stage IV pancreatic adenocarcinoma with
synchronous metastases: A Bi-institutional analysis. J Gastrointest
Surg. 20:1830–1835. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sakaguchi T, Valente R, Tanaka K, Satoi S
and Del Chiaro M: Surgical treatment of metastatic pancreatic
ductal adenocarcinoma: A review of current literature.
Pancreatology. 19:672–680. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Frigerio I, Malleo G, de Pastena M, Deiro
G, Surci N, Scopelliti F, Esposito A, Regi P, Giardino A, Allegrini
V, et al: Prognostic factors after pancreatectomy for pancreatic
cancer initially metastatic to the liver. Ann Surg Oncol.
29:8503–8510. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lu F, Poruk KE and Weiss MJ: Surgery for
oligometastasis of pancreatic cancer. Chin J Cancer Res.
27:358–367. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Clements N, Gaskins J and Martin RCG II:
Surgical outcomes in stage IV pancreatic cancer with liver
metastasis current evidence and future directions: A systematic
review and meta-analysis of surgical resection. Cancers (Basel).
17(688)2025.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shimura M, Mizuma M, Hayashi H, Mori A,
Tachibana T, Hata T, Iseki M, Takadate T, Ariake K, Maeda S, et al:
A long-term survival case treated with conversion surgery following
chemotherapy after diagnostic metastasectomy for pancreatic cancer
with synchronous liver metastasis. Surg Case Rep.
3(132)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Evans DB, Rich TA, Byrd DR, Cleary KR,
Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ and Ames FC:
Preoperative chemoradiation and pancreaticoduodenectomy for
adenocarcinoma of the pancreas. Arch Surg. 127:1335–1339.
1992.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Eikenboom EL, Nasar N, Seier K, Gönen M,
Spaander MCW, O'Reilly EM, Jarnagin WR, Drebin J, D'Angelica MI,
Kingham TP, et al: Survival of patients with resected
microsatellite instability-high, mismatch repair deficient, and
lynch syndrome-associated pancreatic ductal adenocarcinomas. Ann
Surg Oncol. 32:3568–3577. 2025.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sinn M, Denkert C, Striefler JK, Pelzer U,
Stieler JM, Bahra M, Lohneis P, Dörken B, Oettle H, Riess H and
Sinn BV: α-Smooth muscle actin expression and desmoplastic stromal
reaction in pancreatic cancer: Results from the CONKO-001 study. Br
J Cancer. 111:1917–1923. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ikenaga N, Ohuchida K, Mizumoto K, Cui L,
Kayashima T, Morimatsu K, Moriyama T, Nakata K, Fujita H and Tanaka
M: CD10+ pancreatic stellate cells enhance the progression of
pancreatic cancer. Gastroenterology. 139:1041–1051. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sato M, Kojima M, Nagatsuma AK, Nakamura
Y, Saito N and Ochiai A: Optimal fixation for total preanalytic
phase evaluation in pathology laboratories: A comprehensive study
including immunohistochemistry, DNA, and mRNA assays. Pathol Int.
64:209–216. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Thomas RM, Truty MJ, Nogueras-Gonzalez GM,
Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL,
Wolff RA, et al: Selective reoperation for locally recurrent or
metastatic pancreatic ductal adenocarcinoma following primary
pancreatic resection. J Gastrointest Surg. 16:1696–1704.
2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Miyazaki M, Yoshitomi H, Shimizu H,
Ohtsuka M, Yoshidome H, Furukawa K, Takayasiki T, Kuboki S, Okamura
D, Suzuki D and Nakajima M: Repeat pancreatectomy for pancreatic
ductal cancer recurrence in the remnant pancreas after initial
pancreatectomy: Is it worthwhile? Surgery. 155:58–66.
2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Groot VP, Blair AB, Gemenetzis G, Ding D,
Burkhart RA, van Oosten AF, Molenaar IQ, Cameron JL, Weiss MJ, Yang
SC, et al: Isolated pulmonary recurrence after resection of
pancreatic cancer: The effect of patient factors and treatment
modalities on survival. HPB (Oxford). 21:998–1008. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yamada H, Hirano S, Tanaka E, Shichinohe T
and Kondo S: Surgical treatment of liver metastases from pancreatic
cancer. HPB (Oxford). 8:85–88. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Imai K, Margonis GA, Wang J, Wolfgang CL,
Baba H and Weiss MJ: Liver metastases from pancreatic ductal
adenocarcinoma: Is there a place for surgery in the modern era? J
Pancreatol. 3:81–85. 2020.
|
|
19
|
Gu J, Xu Z, Ma Y, Chen H, Wang D, Deng X,
Cheng D, Xie J, Jin J, Zhan X, et al: Surgical resection of
metastatic pancreatic cancer: Is it worth it?-a 15-year experience
at a single Chinese center. J Gastrointest Oncol. 11:319–328.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Klein F, Puhl G, Guckelberger O, Pelzer U,
Pullankavumkal JR, Guel S, Neuhaus P and Bahra M: The impact of
simultaneous liver resection for occult liver metastases of
pancreatic adenocarcinoma. Gastroenterol Res Pract.
2012(939350)2012.PubMed/NCBI View Article : Google Scholar
|
